Home › Funds › Invenomic Capital Management LP › EGO

Invenomic Capital Management LP position in EGO

ELDORADO GOLD CORP NEW · Materials

Invenomic Capital Management LP reported holding 750,722 shares of EGO (ELDORADO GOLD CORP NEW) in its Q3 2026 13F filing — a position valued at US$28.9M, representing 1.43% of its reported portfolio and ranking #27 among its reported holdings. Invenomic Capital Management LP has disclosed EGO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)750.72K sh
Reported value held$28.90M
Portfolio Weight1.43%
First reportedQ3 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Invenomic Capital Management LP's EGO position evolved

Invenomic Capital Management LP first disclosed a stake in EGO in Q3 2023 at 2,289,734 shares (US$20.4M). The position peaked in Q3 2025 at 1,879,102 shares, worth US$54.3M. Across 13 filings, Invenomic Capital Management LP increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 750,722 shares valued at US$28.9M — a reduction of -407,097 shares quarter over quarter.. Notable position changes include a 41% trim in Q4 2023 (shares rose 8% over the following quarter), a 127% increase in Q1 2025 (shares rose 21% over the following quarter), a 35% trim in Q3 2026 (shares fell 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.29M $20.40M New
Q4 2023 1.36M $17.60M Reduce
Q1 2024 1.74M $24.45M Add
Q2 2024 1.64M $24.32M Reduce
Q3 2024 1.15M $20.00M Reduce
Q4 2024 995.85K $14.81M Reduce
Q1 2025 2.26M $38.05M Add
Q2 2025 2.03M $41.33M Reduce
Q3 2025 1.88M $54.29M Reduce
Q4 2025 1.50M $53.75M Reduce
Q1 2026 1.43M $49.22M Reduce
Q2 2026 1.16M $36.00M Reduce
Q3 2026 750.72K $28.90M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EGO and 13F data

EGO (ELDORADO GOLD CORP NEW) is a Materials company. 45 other funds we track also report a position in EGO — the largest reported positions include L1 Capital Pty Ltd (US$555.5M), FAIRFAX FINANCIAL HOLDINGS LTD/ CAN (US$526.7M), VAN ECK ASSOCIATES CORP (US$488.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EGO

All EGO fund holders →

FAQ

How long has Invenomic Capital Management LP held EGO?

Invenomic Capital Management LP has disclosed EGO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Invenomic Capital Management LP's current position in EGO?

As of Q3 2026, Invenomic Capital Management LP holds 750.72K shares of EGO (ELDORADO GOLD CORP NEW), valued at $28.90M, representing 1.43% of its reported portfolio and ranking #27.

Has Invenomic Capital Management LP been buying or selling EGO?

In the latest 13F filing (Q3 2026), Invenomic Capital Management LP reduced its position in EGO. The position peaked in Q3 2025 at 1.88M shares.

Which other funds hold EGO?

Other major institutional holders of EGO include L1 Capital Pty Ltd, FAIRFAX FINANCIAL HOLDINGS LTD/ CAN, VAN ECK ASSOCIATES CORP, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.